Answers are grounded in this paper and cite their sources.
White matter hypointensity on T1-weighted MRI (T1-WMHypo), a putative marker of white matter pathophysiological changes, has been less systematically investigated than the widely studied T2-weighted fluid-attenuated inversion recovery (T2-FLAIR) hyperintensity lesions. Here, we built the lifespan normative reference and assessed the clinical significance of T1-WMHypo across various brain disorders using a large multicenter dataset. We first established lifespan normative reference for T1-WMHypo volume by 34,148 healthy individuals (aged 4-85 years). Then, in 7,587 patients across 21 neurological and psychiatric disorders, normative reference-derived deviations revealed disease-specific patterns, with marked deviations in neurological diseases. Deviations of T1-WMHypo volume contributed to differential diagnosis, larger deviations correlated with brain atrophy, cognitive impairment, and poorer outcomes in various brain disorders. Elevated burden of T1-WMHypo volume predicted poor medication response in Parkinson's disease and accelerated disability progression in multiple sclerosis. These associations persisted after adjusting for conventional T2-FLAIR hyperintensity lesions. T1-WMHypo deviations provide an individualized marker of white matter pathophysiological changes, offering novel insights for precision medicine across development, aging and brain disorders.
No takes yet. Share an insight, caveat, or question.
Zhuo et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: